AKYA Insider Trading Activity and SEC Form 4 Filings
AKYA insider trading summary
No open-market insider purchases or sales of Akoya Biosciences, Inc. (AKYA) have been reported on SEC Form 4 in the past 12 months.
Latest AKYA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 11, 2024 | Brian McKelligon | President and CEO | Sell | $16K (7,500 @ $2.08) |
| Jun 6, 2024 | Brian McKelligon | President and CEO | Sell | $15K (7,500 @ $2.01) |
| Mar 20, 2024 | Brian McKelligon | President and CEO | Sell | $37K (7,500 @ $4.97) |
| Mar 13, 2024 | Brian McKelligon | President and CEO | Sell | $37K (7,500 @ $4.94) |
| Dec 19, 2023 | Brian McKelligon | President and CEO | Sell | $34K (7,500 @ $4.48) |
| Dec 12, 2023 | Brian McKelligon | President and CEO | Sell | $32K (7,500 @ $4.25) |
| Nov 20, 2023 | Brian McKelligon | President and CEO | Sell | $33K (7,500 @ $4.39) |
| Sep 7, 2023 | Frederic Pla | Chief Operating Officer | Buy | $32K (7,000 @ $4.60) |
| Sep 7, 2023 | Frederic Pla | Chief Operating Officer | Buy | $60K (13,000 @ $4.60) |
| Jun 12, 2023 | Thomas A. Raffin | Director | Buy | $100K (20,000 @ $5.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.